Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.00051 | 1 |
mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.0003 | 1 |
mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0004 | 1 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 5.7e-05 | 1 |